ZCA1 rprb-8 (M1); january 31 february 1, 2019;paul cairns; bethesda north marriott hotel & conference center; total hotel cost complies with HHS policy on promoting efficient spending as of 1/3/2012

Ended Awarded Last action

Contract number
75N91019F00022
Awardee
Awarding agency
Obligated
$17,291

Award facts

Contract value 100% obligated
$17,291.11 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
North Bethesda, MD 20852, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00001 · To DE-obligate funds from FY2019 expiring lines following NIH oalm communication 24-16 (20231204) -$6,867
Original award $24,158

About this award

The National Cancer Institute (NCI), a civilian agency within the National Institutes of Health, awarded a Blanket Purchase Agreement (BPA) call to Bsrep II MBN LLC, doing business as the Bethesda North Marriott Hotel & Conference Center, on November 1, 2018. This firm fixed-price contract was awarded without a set-aside designation and carries a ceiling value of $17,291.11. The contract was executed January 31–February 1, 2019, under the direction of Paul Cairns, with performance taking place at the hotel's facilities in Rockville, Maryland. The contract was ultimately completed on March 21, 2024. The award complies with HHS spending efficiency policies established as of January 3, 2012, regarding hotel costs.

Bsrep II MBN LLC is a Marriott International subsidiary specializing in providing hospitality services to federal agencies, with extensive experience supporting NIH scientific peer review meetings and government conferences. The contractor delivers conference spaces, lodging, meeting rooms, and related hospitality services to support agency events and meetings. As a long-standing federal contractor registered in SAM.gov since 2005, the company has a demonstrated track record of performing similar work for multiple NIH institutes and other government agencies. A de-obligation action was processed in December 2023 to return FY2019 expiring funds following NIH Office of Administrative and Management Services communication 24-16.

Quick answers

Who was awarded contract 75N91019F00022?

75N91019F00022 was awarded to Bsrep II MBN LLC by National Cancer Institute (National Institutes of Health) on November 1, 2018.

How much is contract 75N91019F00022 worth?

The government has obligated $17,291 on 75N91019F00022.

Is contract 75N91019F00022 an order under another contract?

Yes. 75N91019F00022 is a BPA call under HHSN263201500186B, a blanket purchase agreement.

Was contract 75N91019F00022 competed?

The extent of competition for 75N91019F00022 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award